Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AMG-900 shows promise in first-in-human trial

July 4, 2012

Safety results presented on new MedImmune immunotherapeutic

July 4, 2012

Milatuzumab evaluated in elderly patients with chronic lymphocytic leukemia

July 3, 2012

Early-stage clinical results disclosed on prodrug for cancer

July 3, 2012

Melatonin MT2 receptor agonist shows promise to treat sleep-related disorders

July 3, 2012

Scientists link new mutations to orofacial clefts and cancer risk

July 3, 2012

Phase Ia trial assesses AGS-009 in patients with SLE

July 3, 2012

GABA(A) receptor modulator improves sleep in human model of insomnia

July 2, 2012

Multiple early-stage trials of MLN-9708 presented

July 2, 2012

FAS-specific antibody for arthritis shows promise in first clinical trial

July 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....